What Pharma Wants From IT Today
Ellen Julian
Life Science Insights
See results from the 2005 Pharmaceutical Executive/Life Science Insights Information Technology Survey.
Informatics Rules
MaryJo Zaborowski, Juergen Hammer, and Gloria Lawler
Roche
Roche's Global Research Informatics organization, formed to facilitate data sharing, is helping to put the company's global network of scientists on the same page.
The Source of Truth
Patrick Clinton
Editor-in-Chief
IT solutions for ensuring compliance are top of mind for pharma execs—and the technology vendors that supply them.
In Search of the Holy Grail
Rob Case
Procter & Gamble Pharmaceuticals
Data integration is improving overall clinical trials management, but quantifying ROI remains a ways off.
Shedding Wings
In this Q&A, Pharm Exec talks to John Hagel about his latest book, and about why he thinks outsourcing decisions should be driven by quality improvement—not cost reduction.
News
GSK's new facility to focus on external drug discovery programs » Medsite's new partnership with Yahoo! » Legislators support FDA's authority to make post-marketing labeling changes. » Tension heightens between PBMs and pharmacists.
Data
Compliance especially important for diabetics » Trust in online health information on the rise.
Thought Leaders
At the helm of Sirius Laboratories, Garry Barnes preaches specialty sales force excellence.
Washington Report
The e-precribing bandwagon is filling up fast.
Jill Wechsler
Global Report
Industry and pharmaceutical wholesalers are both holding out for a ruling on parallel trade in Europe—just not the same one.
Sarah Houlton
Leadership
Leaders today must do more than just keep ahead of trends—they must set them.
Sander A. Flaum
Flaum Partners
Legal Forum
If you provide misleading information and an investor loses, are you to blame?
Pamela Palmer and Jeff Hammel
Latham & Watkins
Direct to Consumer
To regain trust, pharma must invest further in connecting corporate brands more directly with product brands.
Ken Dec
PreVision
Marketing to Professionals
The government plans to link clinical trial evidence with real-world drug applications, says one member of the Medicare Coverage Advisory Committee.
Bryan Luce
United BioSource Corporation
Alternative Media
Perks are in store for pharma companies that jump on the expanding medium of health information portals.
Debrianna Obara
Avenue A/Razorfish
Sales Management
Incentive management helped Wyeth align its reps' rewards with sales strategies after undergoing a merger.
Mark Stiffler
Synergy
From the Editor
The push to ban ED drugs from Medicare reimbursement isn't about their "lifestyle" classification.
Patrick Clinton
Editor-in-Chief
Back Page
Pharma has more in common with tobacco than it may think.
Sarah Wealleans
Landor Associates
People Update
Calendar of Events
Advertisers Index
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.